Company intelligence
LongeVC
We invest in an ageless future.
About LongeVC
We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.
Verified activity
Signals from LongeVC
9 published signals
Presence & Recognition
LongeVC was named a finalist in the VC Firm of the Year category at the European Lifestars Awards.
Reported by LongeVC
Presence & Recognition
LongeVC will be featured as a speaker at the Longevity Investors Conference in Gstaad on September 14-17.
Reported by Garri Zmudze
Presence & Recognition
LongeVC announced that Garri Zmudze will join the Longevity Investors Conference 2026 in Gstaad, Switzerland from September 14 to 17.
Reported by LongeVC
Legal & Regulatory
LongeVC company Sergey Jakimov notes that Generation Lab is offering a private cohort of celebrities, VCs, and biohackers early access to an undisclosed drug combination, with evidence showing insiders feel better.
Reported by Sergey Jakimov
People
LongeVC is still accepting applications for an internship program through the end of this week for graduate students or postdocs.
Reported by LongeVC
Research & Knowledge
LongeVC ran a trial with 1,300 dogs across 70 clinics in veterinary history.
Reported by Garri Zmudze
Research & Knowledge
LongeVC notes that dog life expectancy has doubled in forty years.
Reported by Garri Zmudze
Capital & Finance
LongeVC created a pet-focused venture capital fund AniVC together with Anna Skaya.
Reported by Garri Zmudze
Presence & Recognition
LongeVC principal Artemy Shumskiy is attending the Investment Summit at Advanced Therapies Europe 2026 in Barcelona on September 7.
Reported by LongeVC